Typically, PD‐L1 expression is modulated by a multitude of factors, encompassing inflammatory stimuli and oncogenic pathways, at transcriptional, posttranscriptional, and posttranslational levels within the tumor microenvironment (TME).19 This evidence concerns the gene CD274 and neoplasm.